Dr. Andy Jennings, Senior Consultant Computational Chemistry

Andy Jennings, Ph.D., is a Computational and Medicinal Chemistry Consultant with over 35 years of experience in the fields of Drug Discovery and Medicinal Chemistry. He co-founded and served as Chief Scientific Officer at Liphorus Pharmaceuticals, and was featured in Forbes for his work on small molecule Covid therapeutics and high throughput computing. Dr. Jennings has previously held the roles of VP of Bioinformatics and Lead Discovery at Nitrase Therapeutics, VP of Computational Chemistry at ShouTi (now Structure Therapeutics), led the Computational Sciences and Protein Crystallography groups at Takeda Pharmaceuticals, and held computational chemistry and medicinal chemistry roles at GlaxoSmithKline.